Literature DB >> 16786227

Arterial wall cholesterol content is a predictor of development and severity of arterial thrombosis.

Hongbao Ma1, Kusai S Aziz, Ruiping Huang, George S Abela.   

Abstract

BACKGROUND: It is unclear if total cholesterol content contributes to the severity of cardiovascular events by affecting the amount of thrombosis. This study evaluated relationships between cholesterol levels and the amount of thrombosis in an atherosclerotic rabbit model of plaque disruption and thrombosis.
METHODS: Three groups of NZW rabbits were used: normal rabbits (Group I, n = 4); atherosclerotic rabbits (Group II, n = 4); and atherosclerotic rabbits with pharmacologically triggered thrombosis (Group III, n = 16). Atherosclerosis was induced by feeding a cholesterol enriched diet and balloon deendothelialization. At post-mortem, platelet-rich thrombus and arterial wall cholesterol were quantified and histology performed by light and electron microscopy.
RESULTS: Arterial wall cholesterol was strongly correlated to serum cholesterol in all groups (r = 0.94, p < 0.0001). There was a significant correlation between the thrombus surface area with arterial wall cholesterol in Group III (r = 0.71, p < 0.002). Serum cholesterol, arterial wall cholesterol, and thrombus surface area were all significantly correlated but only arterial wall cholesterol was an independent predictor of thrombosis. A threshold specific for this model was noted for serum and arterial cholesterol levels above which thrombosis consistently occurred.
CONCLUSIONS: Arterial wall cholesterol was strongly correlated to serum cholesterol and thrombosis severity. Serum cholesterol, arterial wall cholesterol and thrombus surface area were all integrally related.A model of plaque disruption and thrombosis was used to demonstrate a correlation between serum and arterial wall cholesterol (r = 0.94; p < 0.0001); arterial wall cholesterol and the amount of thrombosis (surface area; r = 0.71, p < 0.002). A threshold of serum and arterial cholesterol was determined at which thrombosis occurred in this model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16786227     DOI: 10.1007/s11239-006-7861-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  38 in total

1.  Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.

Authors:  Willibald Maier; Lukas A Altwegg; Roberto Corti; Steffen Gay; Martin Hersberger; Friedrich E Maly; Gabor Sütsch; Marco Roffi; Michel Neidhart; Franz R Eberli; Felix C Tanner; Sharon Gobbi; Arnold von Eckardstein; Thomas F Lüscher
Journal:  Circulation       Date:  2005-03-07       Impact factor: 29.690

2.  The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formation.

Authors:  Paul D Thompson; Niall M Moyna; C Michael White; Kelly M Weber; Satyendra Giri; David D Waters
Journal:  Atherosclerosis       Date:  2002-04       Impact factor: 5.162

Review 3.  Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier.

Authors:  J E Muller; G S Abela; R W Nesto; G H Tofler
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

4.  Dietary lipid lowering reduces tissue factor expression in rabbit atheroma.

Authors:  M Aikawa; S J Voglic; S Sugiyama; E Rabkin; M B Taubman; J T Fallon; P Libby
Journal:  Circulation       Date:  1999-09-14       Impact factor: 29.690

5.  Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators.

Authors:  M A Mittleman; M Maclure; G H Tofler; J B Sherwood; R J Goldberg; J E Muller
Journal:  N Engl J Med       Date:  1993-12-02       Impact factor: 91.245

6.  Lipids and risk of coronary heart disease. The Framingham Study.

Authors:  W P Castelli; K Anderson; P W Wilson; D Levy
Journal:  Ann Epidemiol       Date:  1992 Jan-Mar       Impact factor: 3.797

7.  Ultrasonographically assessed carotid morphology and the risk of coronary heart disease.

Authors:  J T Salonen; R Salonen
Journal:  Arterioscler Thromb       Date:  1991 Sep-Oct

8.  Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.

Authors:  G S Abela; P D Picon; S E Friedl; O C Gebara; A Miyamoto; M Federman; G H Tofler; J E Muller
Journal:  Circulation       Date:  1995-02-01       Impact factor: 29.690

9.  An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium.

Authors:  H Li; M I Cybulsky; M A Gimbrone; P Libby
Journal:  Arterioscler Thromb       Date:  1993-02

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  4 in total

1.  Mechanical analysis of arterial plaques in native geometry with OCT wall motion analysis.

Authors:  Claire Robertson; Andrew E Heidari; Zhongping Chen; Steven C George
Journal:  J Biomech       Date:  2013-11-15       Impact factor: 2.712

2.  A robust rabbit model of human atherosclerosis and atherothrombosis.

Authors:  Alkystis Phinikaridou; Kevin J Hallock; Ye Qiao; James A Hamilton
Journal:  J Lipid Res       Date:  2009-01-12       Impact factor: 5.922

Review 3.  Plaque Rupture and Thrombosis: the Value of the Atherosclerotic Rabbit Model in Defining the Mechanism.

Authors:  Oliver G Abela; Chowdhury H Ahsan; Fadi Alreefi; Negar Salehi; Imran Baig; Abed Janoudi; George S Abela
Journal:  Curr Atheroscler Rep       Date:  2016-06       Impact factor: 5.113

Review 4.  Intraplaque haemorrhages as the trigger of plaque vulnerability.

Authors:  Jean-Baptiste Michel; Renu Virmani; Eloïsa Arbustini; Gerard Pasterkamp
Journal:  Eur Heart J       Date:  2011-03-12       Impact factor: 29.983

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.